$VSEE Secures Nasdaq Approval for Continued Listin
Post# of 44880
(Total Views: 18)
Posted On: 10/15/2025 12:46:28 PM
$VSEE Secures Nasdaq Approval for Continued Listing
SAN JOSE, CA / ACCESS Newswire / September 24, 2025 / VSee Health, Inc. (Nasdaq: VSEE) (the "Company"
, a provider of comprehensive telehealth services that customizes telehealth work-flow streams and enhances patient care, today announced that the Company was notified by The Nasdaq Stock Market LLC ("Nasdaq" in a letter dated September 15, 2025, that the Nasdaq Hearings Panel (the "Panel" had granted the Company's request for continued listing on Nasdaq, subject to the Company (i) evidencing compliance with Nasdaq's periodic reporting requirement by filing its Q1 and Q2 Quarterly report ending March 31, 2025 and June 30, 2025 respectively (together, the "Delayed Reports" on Form 10-Q by October 15, and (ii) demonstrating compliance with the Equity Rule by December 1, 2025.
The Company continues to work diligently with its auditor to complete and file the Delayed Reports and expects to do so within the extension period granted by the Panel. The company also plans to address and meet the net equity requirements within the extension period.
About VSee Health
VSee Health (Nasdaq: VSEE) is a rapidly growing leader in AI-powered telehealth, redefining the $787 billion digital healthcare market with its modular, no-code/low-code platform. Trusted by 1,000+ clients, including NASA, the U.S. Department of Health and Human Services, McKesson, DaVita, and the entire nation of Qatar, VSee Health provides foundational infrastructure for digital healthcare and delivers turnkey solutions including critical care, teleradiology, and autonomous robotics to optimize healthcare operations while increasing billable patient visits and provider efficiency. Visit vseehealth.com.
SAN JOSE, CA / ACCESS Newswire / September 24, 2025 / VSee Health, Inc. (Nasdaq: VSEE) (the "Company"
, a provider of comprehensive telehealth services that customizes telehealth work-flow streams and enhances patient care, today announced that the Company was notified by The Nasdaq Stock Market LLC ("Nasdaq" in a letter dated September 15, 2025, that the Nasdaq Hearings Panel (the "Panel" had granted the Company's request for continued listing on Nasdaq, subject to the Company (i) evidencing compliance with Nasdaq's periodic reporting requirement by filing its Q1 and Q2 Quarterly report ending March 31, 2025 and June 30, 2025 respectively (together, the "Delayed Reports" on Form 10-Q by October 15, and (ii) demonstrating compliance with the Equity Rule by December 1, 2025. The Company continues to work diligently with its auditor to complete and file the Delayed Reports and expects to do so within the extension period granted by the Panel. The company also plans to address and meet the net equity requirements within the extension period.
About VSee Health
VSee Health (Nasdaq: VSEE) is a rapidly growing leader in AI-powered telehealth, redefining the $787 billion digital healthcare market with its modular, no-code/low-code platform. Trusted by 1,000+ clients, including NASA, the U.S. Department of Health and Human Services, McKesson, DaVita, and the entire nation of Qatar, VSee Health provides foundational infrastructure for digital healthcare and delivers turnkey solutions including critical care, teleradiology, and autonomous robotics to optimize healthcare operations while increasing billable patient visits and provider efficiency. Visit vseehealth.com.
(0)
(0)
What I post is my opinion. Do your own DD. Make your own investment decision. Links, images, & retweets are not endorsements.
1️⃣I do not provide personal investment advice and I am not a qualified licensed investment advisor. I am an amateur investor.
2️⃣All information found here, including any ideas, opinions, views, predictions, forecasts, commentaries, suggestions, or stock picks, expressed or implied herein, are for informational, entertainment or educational purposes only and should not be construed as personal investment advice. While the information provided is believed to be accurate, it may include errors or inaccuracies.
3️⃣I will not and cannot be held liable for any actions you take as a result of anything you read here.
4️⃣Conduct your own due diligence, or consult a licensed financial advisor or broker before making any and all investment decisions. Any investments, trades, speculations, or decisions made on the basis of any information found on this site, expressed or implied herein, are committed at your own risk, financial or otherwise.
4️⃣Not Financial Advice. What I post is my opinion.
Also Paid for Advertising/IR/PR on Emerging Companies
Full Disclaimer: https://corporateads.com/disclaimer/
1️⃣I do not provide personal investment advice and I am not a qualified licensed investment advisor. I am an amateur investor.
2️⃣All information found here, including any ideas, opinions, views, predictions, forecasts, commentaries, suggestions, or stock picks, expressed or implied herein, are for informational, entertainment or educational purposes only and should not be construed as personal investment advice. While the information provided is believed to be accurate, it may include errors or inaccuracies.
3️⃣I will not and cannot be held liable for any actions you take as a result of anything you read here.
4️⃣Conduct your own due diligence, or consult a licensed financial advisor or broker before making any and all investment decisions. Any investments, trades, speculations, or decisions made on the basis of any information found on this site, expressed or implied herein, are committed at your own risk, financial or otherwise.
4️⃣Not Financial Advice. What I post is my opinion.
Also Paid for Advertising/IR/PR on Emerging Companies
Full Disclaimer: https://corporateads.com/disclaimer/